Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?

Front Psychiatry. 2020 Jun 17:11:579. doi: 10.3389/fpsyt.2020.00579. eCollection 2020.

Bojan Mirkovic^{1

2}, Abdeslam Chagraoui³, Priscille Gerardin^{1

2}, David Cohen^{4

5

6}

¹ Department of Child and Adolescent Psychiatry, CH Le Rouvray, Rouen University Hospital, Rouen, France.
² Université Paris-Saclay, UVSQ, INSERM, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
³ Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Department of Medical Biochemistry, Rouen University Hospital, Rouen, France.
⁴ Department of Child and Adolescent Psychiatry, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
⁵ GRC-15, Approche dimensionnelle des épisodes psychotiques de l'enfant et de l'adolescent, Faculté de Médecine, UPMC, Sorbonne Université, Paris, France.
⁶ CNRS UMR 7222 "Institut des Systèmes Intelligents et Robotiques", Sorbonne Université, Paris, France.

No abstract available

Keywords: attention deficit/hyperactivity disorder; biomarkers; epigenetics; methylation; microRNA.